Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung

Gerald Anderson, Michel Clavel, John Smyth, Guiseppe Giaccone, Marco Gracia, Andre S. Planting, Otilia Dalesio, Anne Kirkpatrick, Gordon McVie

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)909-910
Number of pages2
JournalEuropean Journal of Cancer and Clinical Oncology
Volume25
Issue number5
DOIs
Publication statusPublished - 1989

ASJC Scopus subject areas

  • Oncology

Cite this

Anderson, G., Clavel, M., Smyth, J., Giaccone, G., Gracia, M., Planting, A. S., Dalesio, O., Kirkpatrick, A., & McVie, G. (1989). Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. European Journal of Cancer and Clinical Oncology, 25(5), 909-910. https://doi.org/10.1016/0277-5379(89)90140-5